Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Daiichi vitamin production

This article was originally published in The Tan Sheet

Executive Summary

Daiichi Fine Chemical has decided to stop production of vitamin B6 (pyridoxine HCl) at its Takaoka City, Japan facility effective July 31. Firm cites "poor global market conditions" as primary reason for exiting business. Following July closing date, Daiichi Pharmaceutical subsidiary will utilize facility to produce pharmaceutical intermediates and shift its focus to vitamin B5 (pantothenic acid) production. Firm manufactures 10 different forms of pantothenic acid for use in human nutrition, personal care and pharmaceutical products...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093940

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel